Maine PointeResults. Now.™

U.S. Mandates to Lower Drug Pricing: Actions to Take Now

A 90-day operating playbook for pharma supply chain leaders.

Maine Pointe · Life Sciences practice
9 min read

The 2026 pricing mandates compress margins on roughly 40% of branded portfolios. Manufacturers that move now will protect operating income; those that wait will be negotiating from a deficit.

Cost-to-serve is the new battleground

When list price compresses, every dollar of cost-to-serve flows directly to EBIT. Cold-chain optimization, packaging right-sizing, and 3PL rationalization each become 6-9 month payback projects rather than 18-month ones.

$340M
Annualized COGS reduction identified across a top-10 manufacturer's small-molecule portfolio.

The 90-day actions

  • Renegotiate API contracts with index-linked clauses tied to mandated price points.
  • Consolidate 3PL footprint — most pharma networks carry 30% redundant capacity.
  • Re-platform serialization and traceability investments around the new pricing tier.
Author
Maine Pointe
Life Sciences practice — Maine Pointe
Talk to our team →

Facing this in your business?

Tell us what you're trying to fix. A partner who has done it before will come back to you.

Talk to a partner